PUBLISHER: IMARC | PRODUCT CODE: 1702106
PUBLISHER: IMARC | PRODUCT CODE: 1702106
The global hernia mesh devices market size reached USD 2.06 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.63 Billion by 2033, exhibiting a growth rate (CAGR) of 2.76% during 2025-2033. The increasing number of hospitals, clinics, and ambulatory surgical centers is stimulating the market.
Hernia mesh is a medical device that helps damaged tissue repair around hernias. It is manufactured from absorbable and non-absorbable materials and relies on stitches, staples, or glue to allow tissues for growing into the device. It is implanted into the upper stomach, groin, or abdomen of the patient undergoing hernia surgery to reduce the rate of recurrence of hernia and strengthen the hernia repair. It also improves patient outcomes by decreasing operative time and minimizing recovery time. As a result, hernia mesh device finds extensive applications in hospitals, clinics, and ambulatory surgical centers.
At present, there is a rise in the prevalence of hernia due to obesity, lifting heavy objects, diarrhea or constipation, persistent coughing, poor nutrition, smoking, and overexertion. This, along with the burgeoning healthcare industry, represents one of the key factors driving the market. Besides this, technological advancements in hernia mesh devices, such as articulating fixation devices and self-fixating meshes, to overcome the problems occurring during laparoscopic processes are contributing to the growth of the market. In addition, articulating fixation devices offer surgeons better access to weak spots within the abdominal wall and enable them to securely place the mesh at the desired body site, which is positively influencing the market. Moreover, various benefits offered by hernia mesh devices, such as resistance to infection and enhanced tensile strength to prevent a recurrence, are propelling the growth of the market. Apart from this, there is an increase in the adoption of robotic surgeries across the globe. This, coupled with the growing demand for advanced meshes among the masses, is offering a positive market outlook. Additionally, the rising demand for robotic hernia surgeries due to lower postoperative pain and enhanced surgeon ergonomics is bolstering the growth of the market.
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Becton Dickinson and Company, Cook Group Incorporated, Deep Blue Medical Advances Inc., GEM Srl, Herniamesh S. R. L., Johnson & Johnson, Medtronic plc, Meril Life Sciences Pvt. Ltd., Novus Scientific AB, Samyang Holding Corporation, Stryker Corporation and W. L. Gore & Associates Inc.